Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,957
Closed -$226K 242
2026
Q1
$226K Hold
2,957
﹤0.01% 223
2025
Q4
$220K Sell
2,957
-170,469
-98% -$12.5M ﹤0.01% 230
2025
Q3
$11.7M Buy
173,426
+384
+0.2% +$25.5K 0.11% 90
2025
Q2
$11.3M Buy
173,042
+10,988
+7% +$659K 0.15% 66
2025
Q1
$9.99M Buy
162,054
+9,080
+6% +$602K 0.14% 69
2024
Q4
$10.9M Sell
152,974
-2,454
-2% -$192K 0.15% 66
2024
Q3
$12.6M Buy
155,428
+6,549
+4% +$524K 0.17% 62
2024
Q2
$11.2M Buy
148,879
+3,324
+2% +$249K 0.17% 61
2024
Q1
$11.4M Buy
145,555
+3,650
+3% +$272K 0.17% 59
2023
Q4
$10.2M Buy
141,905
+1,566
+1% +$109K 0.17% 61
2023
Q3
$9.73M Buy
140,339
+127,458
+990% +$9.63M 0.18% 59
2023
Q2
$1.04M Buy
+12,881
New +$1.05M 0.02% 102

Other funds holding HOLX

ABN AMRO Bank's HOLX Position: Q2 2026 in Review

ABN AMRO Bank sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,957 shares — an estimated $226K sold.

ABN AMRO Bank first reported a position in HOLX in Q2 2023 and held it in 12 quarters. The position peaked at $12.6M in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • ABN AMRO Bank reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • ABN AMRO Bank sold 2,957 Hologic shares in Q2 2026, an estimated $226K.
  • ABN AMRO Bank first reported a position in Hologic in Q2 2023 and held it in 12 quarters.
  • ABN AMRO Bank's Hologic position peaked at $12.6M in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.